RecalledThisWeek Search
High risk Drugs & MedicationsClass II

Major Pharmaceuticals Levothyroxine Recall

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed

Updated July 13, 2026

Major Pharmaceuticals is recalling Levothyroxine Sodium 88 mcg tablets because they are subpotent, meaning they contain less active ingredient than labeled. This puts patients at risk of insufficient thyroid hormone replacement.

Is the Major Pharmaceuticals recalled? Yes. This product was recalled by FDA on July 13, 2026. Details below.

What is recalled

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 tablets per carton (10 x 10 unit dose blisters), Rx only, packaged and distributed by Major Pharmaceuticals, Indianapolis, IN 46268. NDC: 0904-6952-61.

Am I affected

You're affected if your prescription bottle shows the NDC number 0904-6952-61 and the strength is 88 mcg levothyroxine sodium tablets.

What to do right now

Contact your pharmacy or Major Pharmaceuticals immediately to return or replace this medication. Do not stop taking your levothyroxine without consulting your doctor, as this could affect your thyroid condition. Ask your doctor or pharmacist for guidance on obtaining a replacement supply.

The hazard

Subpotent Drug

Brands affected

Major Pharmaceuticals
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0703-2026
Classification
Class II
Recalled
July 13, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls